中国宠物处方粮市场
中国宠物处方粮市场：2025年市场规模约为2.177亿美元，2031年市场规模约为3.552亿美元；预测期复合年增长率为8.50%。
市场研究正文
规模、增长、细分、驱动因素与关键问题
当前质量分 100.00，审核状态 accepted。结构化字段已按 RoboInd 内容层级组织。
核心结论
中国宠物处方粮市场：2025年市场规模约为2.177亿美元，2031年市场规模约为3.552亿美元；预测期复合年增长率为8.50%。
市场走势
结构化指标
| 指标 | 年份 | 数值 | 性质 |
|---|---|---|---|
| 复合年增长率 | 2031 | 8.5% | 机构预测 |
| 市场规模 | 2025 | USD 217.7 million | 基准/历史 |
| 市场规模 | 2026 | USD 236.2 million | 机构预测 |
| 市场规模 | 2031 | USD 355.2 million | 机构预测 |
细分市场份额
市场结构
| 维度 | 细分项 | 年份 | 份额 |
|---|---|---|---|
| distribution_channel | the Online channel | 2025 | 59.100% |
| pets | dogs | 2025 | 53.000% |
| sub_product | renal | 2025 | 24.000% |
关键结论
- distribution_channel 维度中，the Online channel 在 2025 年的公开份额为 59.1%。
- pets 维度中，dogs 在 2025 年的公开份额为 53%。
- sub_product 维度中，renal 在 2025 年的公开份额为 24%。
主要参与者
- Mars Incorporated
- Colgate-Palmolive Company (Hills Pet Nutrition Inc.)
- General Mills Inc. (Blue Buffalo)
- Virbac
- Nestlé S.A. (Purina)
增长驱动因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Rising veterinary diagnosis of chronic pet conditions | +2.100% | Tier 1 and Tier 2 cities, early gains in Tier 3 | Short term (≤ 2 years) |
| Pet humanization and therapeutic premiumization | +1.600% | National, strongest in first-tier cities | Medium term (2-4 years) |
| Online veterinary refill and O2O fulfillment expansion | +1.300% | National, concentrated in coastal urban centers | Short term (≤ 2 years) |
| Rising cat ownership and feline-specific nutrition need | +1.100% | National, faster in high-density urban areas | Long term (≥ 4 years) |
| Digitized clinic-to-consumer prescription workflow | +0.900% | Tier 1 and new first-tier cities | Medium term (2-4 years) |
| Growth of condition-specific formulation innovation | +0.700% | National, supply-side driven | Long term (≥ 4 years) |
市场制约因素
| 因素 | 影响 CAGR | 地区相关性 | 影响周期 |
|---|---|---|---|
| Premium pricing versus mainstream pet food | -1.800% | Tier 3 and lower cities, national for mass-market households | Medium term (2-4 years) |
| Regulatory approval and label compliance friction | -1.100% | National | Short term (≤ 2 years) |
| Limited veterinarian dispensing capacity in lower tier cities | -0.800% | Tier 3 to Tier 5 cities and rural markets | Long term (≥ 4 years) |
| Trust gap around clinical efficacy and owner adherence leakage | -0.600% | National | Medium term (2-4 years) |
报告关注的关键问题
How large is the China pet veterinary diet space in 2026?
It stands at USD 236.2 million in 2026 and is projected to reach USD 355.2 million by 2031 at an 8.5% CAGR.
Which condition category leads therapeutic pet food demand in China?
Renal diets led with 24.0% of revenue in 2025, supported by the high burden of chronic kidney conditions in aging pets.
Which condition category is growing fastest through 2031?
Digestive Sensitivity is projected to record the fastest growth at a 9.5% CAGR, supported by high clinic visit rates for gastroenteritis.
Why is online distribution so important in this category?
The Online Channel held 59.1% of revenue in 2025 and supports refill convenience after diagnosis, which improves adherence and repeat purchases.
Are dogs or cats driving faster growth in clinical pet nutrition in China?
Dogs held the larger 53.0% revenue share in 2025, but cats are estimated to grow faster at an 8.5% CAGR through 2031.
市场概览
- 市场集中度：中等
查看来源：Mordor Intelligence